Information Library

Results for: Business transformation - Cost control/reduction - Consulting - Product Development & Commercialization

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • UK Market Access Insight Brief

    White Paper — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • Outsourcing as strategic alternative to your own headcount

    Presentation — May 25, 2010
    Approach of Roche Italy in outsourcing their primary care sales force to Quintiles

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • QUINTILES EXAMINES ASIA-PACIFIC DRUG DEVELOPMENT LANDSCAPE IN NEW REPORT

    Press Release — March 17, 2010 - A new report from Quintiles analyzes the Asia-Pacific pharmaceutical development landscape and its evolution from outsourcing destination to potential innovation hub.

  • QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

    Press Release — November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

  • Anatomy of a Managed Partnership

    Hear from the Experts — May 26, 2009
    Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs.

  • Jim Featherstone, Ph.D.

    Hear from the Experts — March 25, 2009
    Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

  • Gain Capital & Retain Value

    Case Study — March 24, 2009
    Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.

Page 1 of 1 (10 results)

Subscribe to Email Based on Your Interests

Set preferences